The IARC evaluates substances through a systematic process that involves a comprehensive review of available scientific literature. The agency considers both epidemiological studies and experiments in animals. Human evidence might be limited due to the complexity of isolating specific factors causing cancer, while animal studies provide more controlled environments to study potential carcinogens.
